Loading company…
PATHOAI develops AI and big data tools for digital pathology and diagnostics.
Established in 2021 and based in Hangzhou, China, PATHOAI develops AI and big data solutions for pathology. Its products include cervical cancer screening software, pathology image annotation tools, and remote diagnostic services. The company is a subsidiary of Dian Diagnostics Group CO., LTD. In August 2025, it raised pre-Series A funding led by Wanyuandian Fund, with Guangzhou Guoju Venture Capital and Oufang Angel participating, to advance pathology models and pharmaceutical R&D services.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in